Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease — Stella

Home/Liver Disease; Alcohol-Related/Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

View on ClinicalTrials.gov

Recruiting

Back to Liver Disease; Alcohol-Related trials

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Hunter Holmes McGuire VA Medical Center, Richmond, Virginia

Virginia Commonwealth University, Richmond, Virginia

Key details

Phase

Early testing / Safety & dosing

Sponsor

Virginia Commonwealth University

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Enrollment target

~80 participants

Started

November 2022

Primary completion

November 2026

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.